Dandruff (seborrheic dermatitis) - Symptoms, Causes, Treatment & Prevention

```html Dandruff (Seborrheic Dermatitis) – Comprehensive Medical Guide

Dandruff (Seborrheic Dermatitis): A Complete Medical Guide

Overview

Seborrheic dermatitis, commonly known as dandruff when it affects the scalp, is a chronic inflammatory skin condition that primarily targets oily (sebaceous) areas of the body. These include the scalp, eyebrows, eyelids, nasolabial folds, ears, chest, and back. The disorder is characterized by flaking, itching, and erythema (redness) of the skin.

Who it affects: Both men and women can develop seborrheic dermatitis, but it is slightly more prevalent in men (approximately 55 % of cases) and in individuals between the ages of 20‑50. The condition also occurs more frequently in infants (often called cradle cap) and in older adults.

Prevalence: Global estimates suggest that 3–5 % of the adult population has clinically significant seborrheic dermatitis, while up to 20 % may experience mild flaking that does not meet diagnostic criteria. Prevalence is higher in people with neurological diseases (e.g., Parkinson’s disease) and in immunocompromised patients (up to 75 % in HIV‑positive individuals) [1][2].

Symptoms

The clinical presentation can vary depending on the affected site and severity. Common symptoms include:

  • White or yellowish flakes that are easily brushed off the scalp or hair.
  • Itching (pruritus) ranging from mild to severe, often worsening after washing.
  • Red, greasy patches (macules) that may feel oily to the touch.
  • Scaling that can be fine (dandruff) or thick (crusty plaques) especially in the eyebrows, nasolabial folds, and behind the ears.
  • Hair loss (temporary) due to scratching or severe inflammation.
  • Soreness or burning sensation in affected areas.
  • Secondary bacterial or fungal infection signs—pain, drainage, increased redness—if the skin barrier is disrupted.

Causes and Risk Factors

Underlying Pathophysiology

Exact etiology remains multifactorial:

  • Malassezia yeasts (especially M. globosa and M. restricta) proliferate in oily skin, producing irritant fatty acids that trigger inflammation.
  • Sebaceous gland activity – increased sebum provides a nutrient‑rich environment for Malassezia.
  • Immune dysregulation – an abnormal immune response to the yeast or its metabolites.

Risk Factors

  • Age: peaks in adolescence (hormonal surge → more sebum) and after age 50.
  • Male gender.
  • Neurologic disease (Parkinson’s, stroke, traumatic brain injury).
  • Immunosuppression (HIV/AIDS, organ transplantation, chemotherapy).
  • Concurrent skin disorders: psoriasis, rosacea, atopic dermatitis.
  • Climate: colder, drier climates tend to exacerbate flaking; hot, humid climates can worsen greasiness.
  • Stress and fatigue – they can increase sebum production and alter immune function.
  • Certain medications: lithium, interferon‑alpha, psoralen‑UV therapy.

Diagnosis

Diagnosis is primarily clinical, based on history and visual examination.

Step‑by‑step approach

  1. History taking: onset, pattern of flaking, itch severity, associated skin conditions, medication list, and any systemic illnesses.
  2. Physical exam: look for characteristic greasy, yellow‑white scaling on scalp, eyebrows, and nasolabial folds; assess for erythema and secondary infection.
  3. Differential diagnosis – distinguish from psoriasis, atopic dermatitis, contact dermatitis, tinea capitis, and scalp psoriasis.

Diagnostic tests (when needed)

  • Skin scrapings examined with potassium hydroxide (KOH) to rule out tinea (fungal infection).
  • Culture or PCR for Malassezia species (rarely needed).
  • Biopsy in atypical cases to exclude eczema or neoplastic processes.

Treatment Options

Treatment goals are to reduce yeast overgrowth, control inflammation, and restore the skin barrier. Regimens often combine medicated shampoos, topical agents, and lifestyle modifications.

1. Medicated Shampoos (first‑line for scalp involvement)

Active IngredientMechanismTypical Use
Zinc pyrithione (1 %)Antifungal & antibacterial2–3 times weekly; leave on 5 min
Selenium sulfide (1 %)Reduces Malassezia growthTwice weekly; 5–10 min
Ketoconazole (2 %)Broad‑spectrum antifungal2 ×/week; 5 min
Coal tar (0.5–2 %)Anti‑proliferative, anti‑inflammatoryTwice weekly; 5–10 min
Salicylic acid (2 %)Keratinolytic – removes scaleAs needed; may need conditioner after

2. Topical Corticosteroids

Low‑ to mid‑potency steroids (e.g., hydrocortisone 1 % or triamcinolone 0.1 %) applied to affected non‑scalp skin for 2–4 weeks can reduce erythema and itching. Use sparingly to avoid skin atrophy.

3. Topical Antifungals (non‑shampoo)

Cremes or lotions containing clotrimazole, miconazole, or ciclopirox are useful for eyebrows, facial folds, and chest.

4. Calcineurin Inhibitors

Topical tacrolimus 0.1 % or pimecrolimus 1 % are steroid‑sparing options, especially for delicate facial skin. They modulate immune response without the risk of skin thinning [3].

5. Systemic Therapy (for severe or refractory disease)

  • Oral antifungals – fluconazole 100–200 mg weekly or itraconazole 200 mg twice daily for 1 week per month.
  • Systemic corticosteroids – short courses in acute flares, rarely used long‑term.
  • Biologic agents – emerging data on IL‑17/IL‑23 inhibitors for patients with concurrent psoriasis.

6. Lifestyle & Adjunct Measures

  • Gentle shampooing 2–3 times weekly to control sebum, avoiding harsh detergents.
  • Regular use of a soft‑bristle brush to distribute scalp oils evenly.
  • Stress‑reduction techniques (yoga, meditation) – stress can exacerbate flares.
  • Dietary considerations: limiting excessive saturated fats and sugar may help some patients.

Living with Dandruff (Seborrheic Dermatitis)

Daily Management Tips

  1. Stick to a shampoo schedule. Use an anti‑Malassezia shampoo at least twice a week; rotate between two different active agents to prevent tolerance.
  2. Apply topical treatments after washing. While the skin is still slightly damp, apply antifungal cream or low‑potency steroid to affected non‑scalp areas.
  3. Avoid irritants. Harsh hair styling products, alcohol‑based toners, and strong fragrances can worsen inflammation.
  4. Maintain a healthy scalp barrier. Use a lightweight, non‑comedogenic conditioner on the ends of hair only; avoid leaving conditioner on the scalp.
  5. Monitor triggers. Keep a simple journal noting flare‑ups related to stress, weather changes, or new products.
  6. Protect the skin in cold weather. Wear breathable hats, and moisturize facial folds with a fragrance‑free emollient.
  7. Regular follow‑up. Re‑evaluate with a dermatologist every 3–6 months or sooner if symptoms change.

Prevention

  • Maintain scalp hygiene – wash regularly but avoid over‑washing, which can strip natural oils and paradoxically increase sebum production.
  • Use anti‑fungal or anti‑seborrheic shampoos prophylactically during high‑risk seasons (winter).
  • Limit alcohol and tobacco use, both of which can impair the skin barrier and immune response.
  • Manage underlying conditions (e.g., HIV, Parkinson’s) with appropriate medical therapy.
  • Adopt stress‑management strategies: regular exercise, adequate sleep, mindfulness.

Complications

If left untreated or poorly controlled, seborrheic dermatitis can lead to:

  • Secondary bacterial infection – impetiginization, cellulitis.
  • Scarring alopecia – permanent hair loss from chronic inflammation.
  • Exacerbation of other skin diseases (e.g., psoriasis) due to Koebner phenomenon.
  • Social and psychological impact – embarrassment, decreased self‑esteem, and in severe cases, depression.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you notice any of the following:
  • Sudden, severe swelling of the scalp or face accompanied by difficulty breathing or swallowing.
  • Rapidly spreading redness with warmth, fever, or pus – signs of cellulitis or abscess.
  • Severe, unrelenting headache or neurological symptoms (confusion, vision changes) in a patient with known severe seborrheic dermatitis, especially if associated with fever – rare but possible in immunocompromised individuals.

These situations require immediate medical attention to prevent life‑threatening infection or complications.


Sources:

  1. Mayo Clinic. “Seborrheic Dermatitis.” Updated 2023. https://www.mayoclinic.org
  2. CDC. “HIV and Skin Conditions.” 2022. https://www.cdc.gov
  3. Cleveland Clinic. “Topical Calcineurin Inhibitors for Skin Disorders.” 2024. https://my.clevelandclinic.org
```

⚠ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.